{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:55:09Z","timestamp":1791590109275,"version":"4.3.4"},"reference-count":37,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Inflammatory ocular disease (IOD) is a rare but severe extraarticular manifestation of rheumatoid arthritis (ExRA) with high mortality. The aim of our study was to examine clinical characteristics of IOD in rheumatoid arthritis (RA) and their effect on disease severity and outcomes in recent years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A retrospective cohort of RA patients with IOD evaluated between 1996 and 2013 was assembled and compared to RA comparators without IOD and matched for age, sex, and disease duration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>We identified 92 patients (69% female; mean age 62 yrs) with IOD: 33 scleritis, 23 episcleritis, 21 peripheral ulcerative keratitis (PUK), 14 uveitis, and 1 with orbital inflammation. The majority of patients with scleritis, episcleritis, and PUK was seropositive versus uveitis (&gt; 80% vs 62%, p = 0.048). PUK and scleritis were more symptomatic compared to episcleritis and uveitis, and often required systemic therapy. Time to resolution was longer in scleritis than episcleritis (p = 0.01). PUK, scleritis, and uveitis had severe ocular sequelae. Prevalence of severe ExRA (18% vs 4%, p = 0.004) and dry eye syndrome (42% vs 26%, p = 0.024) was higher among patients with IOD than comparators. The incidence of new ExRA over 5-year followup was also higher among cases (29% vs 11%, p = 0.022). Ten-year survival was similar among RA patients with and without IOD (66% vs 64%, p = 0.56), with no differences noted among IOD subtypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>This large single-center study highlights the variable presentation and outcomes of IOD in RA. Although ocular complications are associated with significant morbidity, it is reassuring that survival among those with IOD is now similar to those without ocular disease.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.170437","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T20:20:23Z","timestamp":1518726023000},"page":"595-603","source":"Crossref","is-referenced-by-count":42,"title":["Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era"],"prefix":"10.3899","volume":"45","author":[{"given":"Cristian","family":"Caimmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashima","family":"Makol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"key":"2018112909383039000_45.5.595.1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32835f693f"},{"key":"2018112909383039000_45.5.595.2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00006853"},{"key":"2018112909383039000_45.5.595.3","first-page":"393","article-title":"Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies","volume":"9","author":"Vignesh","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"2018112909383039000_45.5.595.4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101133"},{"key":"2018112909383039000_45.5.595.5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2018112909383039000_45.5.595.6","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0454"},{"key":"2018112909383039000_45.5.595.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(84)34160-4"},{"key":"2018112909383039000_45.5.595.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381114"},{"key":"2018112909383039000_45.5.595.9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.3.190"},{"key":"2018112909383039000_45.5.595.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.1.7"},{"key":"2018112909383039000_45.5.595.11","first-page":"62","article-title":"Occurrence of extra-articular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis","volume":"29","author":"Turesson","year":"2002","journal-title":"J Rheumatol"},{"key":"2018112909383039000_45.5.595.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200303203481225"},{"key":"2018112909383039000_45.5.595.13","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10792-015-0124-0","article-title":"Biologic therapy for refractory scleritis: a new treatment perspective","volume":"35","author":"de Fidelix","year":"2015","journal-title":"Int Ophthalmol"},{"key":"2018112909383039000_45.5.595.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2018112909383039000_45.5.595.15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.7.668"},{"key":"2018112909383039000_45.5.595.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.8.722"},{"key":"2018112909383039000_45.5.595.17","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.60.3.163"},{"key":"2018112909383039000_45.5.595.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"2018112909383039000_45.5.595.19","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.60.3.192"},{"key":"2018112909383039000_45.5.595.20","first-page":"1161","article-title":"Rheumatoid scleritis: a long-term follow up","volume":"66","author":"Jones","year":"1973","journal-title":"Proc R Soc Med"},{"key":"2018112909383039000_45.5.595.21","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199507000-00010"},{"key":"2018112909383039000_45.5.595.22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.12.1245"},{"key":"2018112909383039000_45.5.595.23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0161-6420(92)31927-X","article-title":"Penetrating keratoplasty in patients with rheumatoid arthritis","volume":"99","author":"Palay","year":"1992","journal-title":"Ophthalmology"},{"key":"2018112909383039000_45.5.595.24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/112067210601600602","article-title":"Rheumatoid keratolysis: a series of 40 eyes","volume":"16","author":"Malik","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"2018112909383039000_45.5.595.25","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000008"},{"key":"2018112909383039000_45.5.595.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-014-2696-1"},{"key":"2018112909383039000_45.5.595.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(94)31325-X"},{"key":"2018112909383039000_45.5.595.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.07.013"},{"key":"2018112909383039000_45.5.595.29","first-page":"291","article-title":"Uveitis and joint diseases: a review of 191 cases","volume":"64","author":"Kimura","year":"1996","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2018112909383039000_45.5.595.30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0161-6420(91)32280-2","article-title":"Immunopathology of scleritis","volume":"98","author":"Fong","year":"1991","journal-title":"Ophthalmology"},{"key":"2018112909383039000_45.5.595.31","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198107000-00004"},{"key":"2018112909383039000_45.5.595.32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/eye.2001.161","article-title":"Does the shared epitope genotype influence either the susceptibility to or the phenotype of corneal melting?","volume":"15","author":"McKibbin","year":"2001","journal-title":"Eye"},{"key":"2018112909383039000_45.5.595.33","first-page":"179","article-title":"Clustering of extraarticular manifestations in patients with Rheumatoid arthritis","volume":"35","author":"Turesson","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909383039000_45.5.595.34","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.8.941"},{"key":"2018112909383039000_45.5.595.35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3816\/CLM.2006.n.053","article-title":"Scleritis complicating zoledronic acid infusion","volume":"7","author":"Benderson","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"2018112909383039000_45.5.595.36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0025-7753(02)72464-0","article-title":"Episcleritis secondary to risedronate","volume":"118","author":"Vi\u00f1as","year":"2002","journal-title":"Med Clin"},{"key":"2018112909383039000_45.5.595.37","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X14566424"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.170437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T14:29:07Z","timestamp":1543501747000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.170437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,1]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.3899\/jrheum.170437"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.170437","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]}}}